Substance use and psychotherapeutic medications: A likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus
Authors:
- Mardge CohenMCMardge Cohen
- Suzanne E. OhmitSOSuzanne E. Ohmit
- Paula SchumanPSPaula Schuman
- Susan Cu-UvinSCSusan Cu-Uvin
- Xihong LinXLXihong Lin
- Ruth GreenblattRGRuth Greenblatt
- Alejandra GurtmanAGAlejandra Gurtman
- Ann KhalsaAKAnn Khalsa
- Howard MinkoffHMHoward Minkoff
- Mary A. YoungMYMary A. Young
- Robert S. KleinRKRobert S. Klein
- 1 April 2003
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 188 (4) , 881-886
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hypothalamic dysfunctionMolecular and Cellular Endocrinology, 2001
- Mortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive WomenJAMA, 2001
- Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipraminePsychopharmacology, 2000
- Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical StudiesPharmacology Biochemistry and Behavior, 1997
- Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challengePsychiatry Research, 1995
- Menstrual changes with antipsychotic drugsThe British Journal of Psychiatry, 1993
- SMOKING AND ESTROGEN-RELATED DISEASEAmerican Journal of Epidemiology, 1984
- The major medical sequelae of opioid addictionDrug and Alcohol Dependence, 1980
- The Effect of Neuroleptics on Serum Prolactin in Schizophrenic PatientsArchives of General Psychiatry, 1976
- Galactorrhea-amenorrhea syndrome associated with heroin addictionAmerican Journal of Obstetrics and Gynecology, 1974